1 Estimating the Gestational Age and Pregnancy Trimester in the Niger Maternal Nutrition Project Rebecca R. Young, K. Ryan Wesse

Total Page:16

File Type:pdf, Size:1020Kb

1 Estimating the Gestational Age and Pregnancy Trimester in the Niger Maternal Nutrition Project Rebecca R. Young, K. Ryan Wesse Estimating the Gestational Age and Pregnancy Trimester in the Niger Maternal Nutrition Project Rebecca R. Young, K. Ryan Wessells, Césaire T. Ouédraogo, Sonja Y. Hess Program in International and Community Nutrition, Department of Nutrition, University of California, Davis, CA, USA Corresponding authors: Rebecca R. Young ([email protected]) and K. Ryan Wessells ([email protected]) Study Overview The Niger Maternal Nutrition (NiMaNu) project is an implementation research project, using a quasi- experimental descriptive study design. Households with potentially eligible pregnant women from 85 randomly selected villages within the catchment area of 18 integrated health centers (CSI) were identified by employing a multi-stage clustered sampling design. Briefly, 18 CSI serving rural areas were selected by convenience sampling and randomized to the timing of participation. Within the catchment area of each CSI, 6-8 villages were randomly selected from each CSI. Participants were enrolled over a period of eighteen months through two community-based cross sectional surveys conducted at baseline and six months later after the implementation of a programmatic intervention (i.e. endline survey). The study was approved by the National Ethic Committee in Niamey (Niger) and the Institutional Review Board of the University of California, Davis (USA). Participants were asked to sign a written consent or fingerprint. The study was registered at www.ClinicalTrial.Gov as NCT01832688. Data Collection to Date Gestational Age Each study participant was interviewed and examined twice one month apart. Because ultrasound was not available and the majority of study participants were illiterate, several methods were used to date a woman’s gestational age. First, pregnant women were asked to estimate their last menstrual period (LMP) based on a time reference they were most familiar with. A woman could report her LMP by recalling the month and date of her LMP, by reporting the lunar position during her LMP and the number of lunar cycles since her LMP, and/or by reporting her LMP in proximity to a religious or cultural event. Women were also asked whether they had already felt the baby move and if that was the case, if they could estimate the time in months since quickening. Additionally, women were asked if 1 they were showing at the time of their first ANC visit. If a woman dropped out of the study before the second visit, it was recorded why she had dropped-out. Therefore, we knew if a woman gave birth to a live baby between the first visit and the scheduled time of the second visit. Symphysis-fundal height (SFH) was measured in duplicate on two occasions one month apart. During each physical exam, women were asked to empty their bladder and resume a supine position. SFH was measured from the symphysis pubis to the fundus uteri using a metric non-elastic tape (ShorrFlipTape©, Weigh and Measure LLC, Olney, MD)(1). The measurement was repeated and if the difference was >0.5 cm, a third measurement was repeated. Estimation of Gestational Age by Various Methods Based on the multitude of information provided by each woman, gestational age was estimated as follows: 1), the LMP was estimated based on the recall date, the lunar information and/or the local calendar. Using a lunar chart, the LMP was estimated, based on the phase of the moon during the last LMP and the number of moon cycles since the last LMP, and the phase of the moon at the time of the interview. If women remembered when their last LMP occurred in relationship to a major holiday (for instance, 2 weeks before a specific holiday), local holiday calendars were used to estimate the date of her last LMP. 2) Gestational age was assessed based on the number of weeks that had elapsed since the first quickening was felt. It was assumed that the first quickening was felt at 16 weeks gestation for multiparous women and 19 weeks gestation for primiparous women(2). 3) Fundal heights were measured in duplicate during two physical exams one month apart. The INTERGROWTH-21st equation for fundal height was then used to estimate gestational age(3). An extrapolation of gestational age was performed for fundal heights over 38 cm and under 20 cm. Accessing the Accuracy of the Gestational Age Estimations As these measurements were all estimations and prone to errors, a set of logic checks were used to estimate the reliability of each measurement. There were five logic checks: 1.) If quickening had not yet been felt it was assumed that the multiparous woman was less than 20 weeks pregnant, if quickening had not yet been felt it was assumed that the primiparous woman was less than 21 weeks pregnant. If quickening had been felt it was assumed that a multiparous women was more than 13 weeks pregnant and a primiparous women was more than 16 weeks pregnant. 2.) It was assumed that if a woman had 2 not yet started to show that she was less than 21 weeks pregnant and if she had started to show she was over 9 weeks pregnant. 3.) If the woman dropped out of the study before the second visit because she had given birth and that child was born alive, it was assumed that the baby’s gestation age was at least 27 weeks at time of birth. 4.) If SFH was available for both visits, SFH was considered acceptable, if the second SFH was not more than 12 cm greater than the first SFH or 6 cm less than the first SFH. 5.) It was assumed that no woman was less than 15 days pregnant and no woman was more than 43 weeks pregnant. Not all women had each estimate for gestational age, in fact no women had all six measurements. Additionally, the logic checks filtered away many gestational age estimates that were not possible. If any gestational age measurement did not pass a logic check, it was excluded. For example if gestational age as measured by the lunar cycle calculated a woman to be 20 weeks in gestation at the first visit, but she had given live birth less than 1 month later, than it was assumed that the lunar cycle gestational age estimate was incorrect. Creating a Weighted Average of Gestational Age The overall gestational age estimation was calculated as a weighted average. The weighted average was based on two factors: 1.) the percentage of time that each measurement passed the logic checks (which ranged from 70-90%) and 2.) an assigned importance measurement. It was determined that the self- reported methods of gestational age estimation (reported date, lunar cycle and proximity to a holiday) together counted for 1/3rd of the total score, the two SFH together accounted for 1/3rd of the score and the time of first quickening counted for 1/3rd of the score. The weighted average was calculated in such a way that if a measurement was missing (due to either missing information or a failed logic check), the other values would compensate for this missing value. If there was only one known measurement, then the gestational age was estimated based solely on that measurement. References 1. Engstrom JL, Chen EH (1984) Prediction of birthweight by the use of extrauterine measurements during labor. Res Nurs Health 7, 315-323. 2. Levene M, Tudehope D, Thearle M (2000) Essentials in Neonatal Medicine: Wiley. 3 3. Papageorghiou A, Ohuma E, Gravett M et al. (2016) International standards for symphysis-fundal height based on serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH- 21st Project: prospective cohort study in eight countries. Br Med J 355, i5662. 4 .
Recommended publications
  • Symphysio Fundal Height (SFH) Measurement As a Predictor of Birth Weight
    Faridpur Med. Coll. J. 2012;7(2):54-58 � Original Article Symphysio Fundal Height (SFH) Measurement as a Predictor of Birth Weight Z Parvin1, S Shafiuddin2, MA Uddin3, F Begum4 Abstract : Fetal weight is a very important factor to make a decision about labor and delivery. Assuming that in large fetuses, dystocia and other complications like cerebral edema, neurological damage, hypoxia and asphyxia may result during or after the delivery. On the other hand, one of the causes of high perinatal mortality in our country is high rate of low birth weight. Rural people may not have access to ultrasonography which is one of the methods to predict birth weight. For these people alternative easy method is necessary. So we can assess fetal birth weight by measuring symphysio-fundal height. Total 100 consecutive pregnant women of gestational age more than 32 weeks admitted for delivery in the Obstetric and Gynaecology department of Faridpur General Hospital were the subject of this study. After selection of cases, a thorough clinical history was taken and elaborate physical examination was done. Common criteria for collection of data were followed in every case. The fetal weight estimated by Johnson's formula was recorded in the predesigned data sheet and then was compared with birth weight following delivery of the fetus. Collected data were compiled and relevant statistical calculations were done using computer based software. Statistical tests (Correlation) were done between actual birth weight (taken as dependant variable) and fetal weight (found by Johnson's Formula), symphysio fundal height (SFH), pre-delivery weight and height of the patients (taken as independent variables) and the tests revealed that actual birth weight was significantly correlated with fetal weight (found by Johnson's Formula), SFH, pre-delivery weight and height of the patients.
    [Show full text]
  • Magnetic Resonance Imaging
    Published online: 2021-07-30 OBS/GYNEC Magnetic resonance imaging ‑ A troubleshooter in obstetric emergencies: A pictorial review Rohini Gupta, Sunil Kumar Bajaj, Nishith Kumar, Ranjan Chandra, Ritu Nair Misra, Amita Malik, Brij Bhushan Thukral Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India Correspondence: Dr. Rohini Gupta, Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi ‑ 110 029, India. E‑mail: [email protected] Abstract The application of magnetic resonance imaging (MRI) in pregnancy faced initial skepticism of physicians because of fetal safety concerns. The perceived fetal risk has been found to be unwarranted and of late, the modality has attained acceptability. Its role in diagnosing fetal anomalies is well recognized and following its safety certification in pregnancy, it is finding increasing utilization during pregnancy and puerperium. However, the use of MRI in maternal emergency obstetric conditions is relatively limited as it is still evolving. In early gestation, ectopic implantation is one of the major life‑threatening conditions that are frequently encountered. Although ultrasound (USG) is the accepted mainstay modality, the diagnostic predicament persists in many cases. MRI has a role where USG is indeterminate, particularly in the extratubal ectopic pregnancy. Later in gestation, MRI can be a useful adjunct in placental disorders like previa, abruption, and adhesion. It is a good problem‑solving tool in adnexal masses such as ovarian torsion and degenerated fibroid, which have a higher incidence during pregnancy. Catastrophic conditions like uterine rupture can also be preoperatively and timely diagnosed. MRI has a definite role to play in postpartum and post‑abortion life‑threatening conditions, e.g., retained products of conception, and gestational trophoblastic disease, especially when USG is inconclusive or inadequate.
    [Show full text]
  • International Standards for Symphysis-Fundal Height Based on BMJ: First Published As 10.1136/Bmj.I5662 on 7 November 2016
    RESEARCH OPEN ACCESS International standards for symphysis-fundal height based on BMJ: first published as 10.1136/bmj.i5662 on 7 November 2016. Downloaded from serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: prospective cohort study in eight countries Aris T Papageorghiou,1 Eric O Ohuma,1,2 Michael G Gravett,3,4 Jane Hirst,1 Mariangela F da Silveira,5,6 Ann Lambert,1 Maria Carvalho,7 Yasmin A Jaffer,8 Douglas G Altman,2 Julia A Noble,9 Enrico Bertino,10 Manorama Purwar,11 Ruyan Pang,12 Leila Cheikh Ismail,1 Cesar Victora,6 Zulfiqar A Bhutta,13 Stephen H Kennedy,1 José Villar,1 On behalf of the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) For numbered affiliations see ABSTRACT visible during examination. The best fitting curve was end of article. OBJECTIVE selected using second degree fractional polynomials Correspondence to: To create international symphysis-fundal height and further modelled in a multilevel framework to A Papageorghiou, Nuffield standards derived from pregnancies of healthy women account for the longitudinal design of the study. Department of Obstetrics & Gynaecology, University of with good maternal and perinatal outcomes. RESULTS Oxford, John Radcliffe Hospital, DESIGN Of 13 108 women screened in the first trimester, 4607 Headington, Oxford OX3 9DU, UK aris.papageorghiou@obs-gyn. Prospective longitudinal observational study. (35.1%) met the study entry criteria. Of the eligible ox.ac.uk SETTING women, 4321 (93.8%) had pregnancies without major Additional material is published Eight geographically diverse urban regions in Brazil, complications and delivered live singletons without online only.
    [Show full text]
  • Maternal Assessment 1
    University of Babylon / College of Nursing University of Babylon College of Nursing MATERNAL ASSESSMENT 1 SUPERVISOR BY : - DR.AMEAN STUDEND NAME: - ZAINAB ALI HUSSEIN ROSSUL HAMZA ALYAA NEMIA The aim of maternal assessment 2 1- to identify the high risk of cases 2- to prevent and treat early complication 3- to ensure from contained risk assessment and provide on going to primary health care 4- educate the mother about physiology of pregnancy and labor and care newborn The procedures of the first visit 3 1- Demographic data ( age – occupation- LMP- EDD- P G A- type of labor – blood group + RH) 2- Family history 3- past history 4 -obstetric history 5 -mensterial history Signs of pregnancy 4 - Breast changes - Nausea & vomiting - Amenorrhea - Frequent urination - Fatigue & uterine enlargement - Line anigra - Melasma - Goodell signs - Hegar signs - Braxton contraction First Trimester 5 * (Subjective symptoms) - Amenorrhoea - Morning sickness - Frequent of micturation - Breast discomfort - Fatigue - breast changes Objective signs 6 - breast changes - abdominal enlargment - pelvic changes * ( THE TESTING FOR DIAGNOSIS OF PREGNANCCY IN FIRST TRIMESTER ( BHCG) AND ( U/S) 7 -gestational sac( 29-35) day of gestation - gastational age to determine by the detecting the following structures - cardiac activity in (6 week) and heart rate at (10 weeks) - embryo growth by 7 weeks Second trimester 8 General examination - Breast changes - Enlargment of lower abdomen - abdomenal examination :- included:- a-inspaction:-
    [Show full text]
  • The Stunted Development of in Vitro Fertilization in the United States, 1975-1992
    EMBRYONIC POLICIES: THE STUNTED DEVELOPMENT OF IN VITRO FERTILIZATION IN THE UNITED STATES, 1975-1992 Erin N. McKenna A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF ARTS May 2006 Committee: Dr. Leigh Ann Wheeler, Advisor Dr. Walter Grunden ii Abstract The federal government’s failure to fund research on in vitro fertilization has had an important legacy and significant consequences in the United States. Due to the dismantling of the Ethics Advisory Board in 1980, no government funding was provided for research for in vitro fertilization (IVF), embryo transfer (ET), and gamete intra-fallopian transfer (GIFT). The lack of government funding, regulation, and involvement has resulted in the false advertising of higher success rates to lure patients into the infertility specialists’ offices. In their desperation to have children, consumers of such medical technologies paid exorbitant fees that often remained uncovered by insurance companies. The federal government enacted legislation in 1992 attempting to alleviate some of the aspects of exploitation of the consumer-patient. The government’s recognition of the importance of such procedures was hit and miss, though, much like the reproductive technology itself. The legacy is one that has resulted in American citizens who now turn to developing countries such as Israel and India, where the treatment is drastically cheaper and often more effective. I attempt to explain the federal government’s response to New Reproductive Technologies (NRTs), beginning with in vitro fertilization, thus exploring why and how this debate has inextricably been linked to the ongoing abortion debate.
    [Show full text]
  • Pregnancy Tracker
    Women’sPregnancy WelcomeHealth Specialists Packet #5 Pregnancy Tracker It can be confusing to figure out “how far along” you are. A normal pregnancy is dated most times by a patient’s last menstrual period. If a patient is uncertain of when her last menstrual period occurred than an ultrasound may be used to date the pregnancy. A normal pregnancy lasts 42 weeks and your due date is 40 weeks from your last menstrual period. A full term pregnancy is any pregnancy beyond 37 weeks. What to Expect Each Month of Your Pregnancy Office Hours: Our office hours are 9:00-12:00 and 1:00-4:00 Monday through Friday. We are closed on the weekends. If you need to reach a doctor after hours or on the weekend please dial 770-474-0064 and instructions will be given. Calculating Your Due Date The estimated date of delivery (EDD), also known as your due date, is most often calculated from the first day of your last menstrual period. In order to estimate your due date take the date that your last normal menstrual cycle started, add 7 days and count back 3 months. Pregnancy is assumed to have occurred 2 weeks after your last cycle and therefore 2 weeks are added to the beginning of your pregnancy. Pregnancy actually lasts 10 months (40 weeks) and not 9 months. Most women go into labor within 2 weeks of their due date either before or after their actual EDD. For more information, please visit www.girldocs.com First Month (0-4 weeks) Fetal Growth Your Health Sperm fertilizes the egg in one of the fallopian tubes and During this time it is important you take a multivitamin then 5-7 days later the fertilized egg implants (attaches) supplement that contains folic acid 0.4 milligrams daily.
    [Show full text]
  • Best Practice & Research Clinical Obstetrics and Gynaecology
    Author's personal copy Best Practice & Research Clinical Obstetrics and Gynaecology 23 (2009) 809–818 Contents lists available at ScienceDirect Best Practice & Research Clinical Obstetrics and Gynaecology journal homepage: www.elsevier.com/locate/bpobgyn 6 Fetal growth screening by fundal height measurement Kate Morse, Bsc (Hons) DPSM RM RGN, Specialist Midwife, Amanda Williams, MSc Dip HE RM RGN, Specialist Midwife, Jason Gardosi, MD FRCOG FRCSED, Professor * West Midlands Perinatal Institute, Birmingham B6 5RQ, UK Keywords: Fundal height assessment is an inexpensive method for screening fundal height for fetal growth restriction. It has had mixed results in the litera- symphysio-fundal height ture, which is likely to be because of a wide variety of methods customised charts used. A standardised protocol of measurement by tape and plot- ultrasound scan ting on customised charts is presented, which in routine practice fetal biometry has shown to be able to significantly increase detection rates, uterine artery Doppler while reducing unnecessary referral for further investigation. Fundal height measurement needs to be part of a comprehensive protocol and care pathway, which includes serial assessment, referral for ultrasound biometry and additional investigation by Doppler as required. Ó 2009 Published by Elsevier Ltd. The urgency for improving antenatal detection of the small-for-gestation (SGA) or intrauterine growth-restricted (IUGR) baby increases with the awareness that fetal growth restriction is a common precursor of adverse outcome. While we have yet to establish reliable tests to predict which pregnancies are at risk of developing IUGR, surveillance of fetal growth in the third trimester of pregnancy continues to be the mainstay for the assessment of fetal well-being.
    [Show full text]
  • FETAL GROWTH and DEVELOPMENT Copyright© 1995 by the South Dakota Department of Health
    FETAL GROWTH AND DEVELOPMENT Copyright© 1995 by the South Dakota Department of Health. All rights reserved. The South Dakota Department of Health acknowledges Keith L. Moore, Ph.D., F.I.A.C, F.R.S.M.; T.V.N. Persaud, M.D., Ph.D., F.R.C. Path (Lond): Cynthia Barrett, M.D.; and Kathleen A. Veness-Meehan, M.D.; for their professional assis- tance in reviewing this booklet. Photos on pages 8, 9, 11, 13, 16 and 18 by Lennart Nilsson, of Sweden, A Child is Born, 1986, Dell Publishing and are used by permission. Lennart Nilsson is a pioneer in medical photography, credited with inventing numerous devices and techniques in his field. The photos used in this booklet have been published internationally in scientific periodicals and used in the popular press and television. Illustrations on pp. 5 and 6 by Drs. K.L. Moore, T.V.N. Persaud and K. Shiota, Color Atlas of Clinical Embryology, 1944, Philadelphia: W.B. Saunders, are used by permission. The South Dakota Department of Health also acknowledges the technical assis- tance of the following in development of the booklet: Gary Crum, Ph.D., Ann Kappel and Arlen Pennell of the Ohio Department of Health; Sandra Van Gerpen, M.D. M.P.H., Terry Englemann, R.N., Colleen Winter, R.N., B.S.N., and Nancy Shoup, R.N., B.S.N., of the South Dakota Department of Health; Dennis Stevens, M.D.; Virginia Johnson, M.D.; Brent Lindbloom, D.O.; Dean Madison, M.D.; Buck Williams, M.D.; Roger Martin, R.N., C.N.P., M.S.; Barbara Goddard, B.S., Ph.D.; Laurie Lippert; Vincent Rue, P.h.D.; and Representative Roger Hunt.
    [Show full text]
  • Maternal Perception of Fetal Movements: a Qualitative Description
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by ResearchArchive at Victoria University of Wellington MATERNAL PERCEPTION OF FETAL MOVEMENTS: A QUALITATIVE DESCRIPTION BY BILLIE BRADFORD A thesis submitted to the Victoria University of Wellington in fulfilment of the requirements for the degree of Master of Midwifery Victoria University of Wellington 2014 Abstract Background: Maternal perception of decreased fetal movements is a specific indicator of fetal compromise, notably in the context of poor fetal growth. There is currently no agreed numerical definition of decreased fetal movements, with subjective perception of a decrease on the part of the mother being the most significant definition clinically. Both qualitative and quantitative aspects of fetal activity may be important in identifying the compromised fetus.Yet, how pregnant women perceive and describe fetal activity is under-investigated by qualitative means. The aim of this study was to explore normal fetal activity, through first- hand descriptive accounts by pregnant women. Methods: Using qualitative descriptive methodology, interviews were conducted with 19 low-risk women experiencing their first pregnancy, at two timepoints in their third trimester. Interview transcripts were later analysed using qualitative content analysis and patterns of fetal activity identified were then considered along-side the characteristics of the women and their birth outcomes. Results: Fetal activity as described by pregnant women demonstrated a sustained increase in strength, frequency and variation from quickening until 28-32 weeks. Strength of movements continued to increase at term, but variation in movement types reduced. Kicking and jolting movements decreased at term with pushing or stretching movements dominating.
    [Show full text]
  • Licit and Illicit Drug Use During Pregnancy: Maternal, Neonatal and Early Childhood Consequences
    SUBSTANCE ABUSE IN CANADA 2013 Licit and Illicit Drug Use during Pregnancy: Maternal, Neonatal and Early Childhood Consequences By Loretta Finnegan With A Call to Action by Franco Vaccarino and Colleen Dell This document was published by the Canadian Centre on Substance Abuse (CCSA). CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of the Government of Canada. The subjects in the photographs used throughout this publication are models who have no relation to the content. The vignettes are fictional and do not depict any actual person. Suggested citation: Finnegan, L. (2013). Substance abuse in Canada: Licit and illicit drug use during pregnancy: Maternal, neonatal and early childhood consequences. Ottawa, ON: Canadian Centre on Substance Abuse. © Canadian Centre on Substance Abuse 2013. CCSA, 75 Albert St., Suite 500 Ottawa, ON K1P 5E7 Tel.: 613-235-4048 Email: [email protected] This document can also be downloaded as a PDF at www.ccsa.ca. Ce document est également disponible en français sous le titre : Toxicomanie au Canada 2013 : Consommation de drogues licites et illicites pendant la grossesse : Répercussions sur la santé maternelle, néonatale et infantile ISBN 978-1-77178-041-4 Licit and Illicit Drug Use during Pregnancy: Maternal, Neonatal and Early Childhood Consequences Prepared for the Canadian Centre on Substance Abuse Loretta P. Finnegan, M.D., LLD, (Hon.), ScD (Hon.); President, Finnegan Consulting, LLC; Professor of Pediatrics, Psychiatry and Human Behavior, Thomas Jefferson University (Retired); Founder and Former Director of Family Center, Comprehensive Services for Pregnant Drug Dependent Women, Philadelphia, PA; Former Medical Advisor to the Director, Office of Research on Women’s Health, National Institutes of Health, U.S.
    [Show full text]
  • Fetal Outcome in Pregnant Women with Reduced Fetal Movements. Int J Health Sci Res
    International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Fetal Outcome in Pregnant Women with Reduced Fetal Movements Syeda.R.M1, Shakuntala.P.N1*, Shubha.R.Rao1, Sharma.S.K1, Claudius. S2 1Department of Obstetrics and Gynaecology, 2Department of Radiology. St.Martha’s Hospital, Nrupathunga Road, Bengaluru-560070, Karnataka, India. *Correspondence Email: [email protected] Received: 03/04//2013 Revised: 07/05/2013 Accepted: 20/05/2013 ABSTRACT Objectives: To analyse the fetal outcome following reduced fetal movements monitored by cardiotocogram and Biophysical Profile Score (BPP) at onset of complaints and before delivery. Material and Methods: Present study was a prospective observational study conducted in the Department of Obstetrics and Gynaecology St. Martha’s Hospital over a period of 13 months from 01/03/2009 to 31/03/2010 It included 50 pregnant women after 32 weeks of gestation and singleton pregnancies with < 12 fetal movements in 24 hours. They underwent a cardiotocogram(CTG) or a non stress test(NST) and biophysical profile test(BPP) and results were analysed statistically. Results: A non -reactive CTG on admission was encountered in 2/50(04%) vs 21/50(42%);(p<0.001) of women with reduced fetal movements at delivery. Majority 20/50(40%) of the caesarean sections were emergency due to non reassuring CTG. Neonatal birth weight <2500 grams was recorded in 25/50(50%) and 10/26(38.46%) had meconium staining of liquor indicating an unfavorable intra uterine environment. When birth weight <2500 and >2500 grams, NRCTG (non reactive CTG) at the time of delivery was 42.30% vs 37.50%;( p value 0.393) respectively and was not significantly related.
    [Show full text]
  • Decreased Fetal Movements Policy
    Document ID: MATY115 Version: 1.0 Facilitated by: Billie Bradford Last reviewed: June 2019 Approved by: Maternity Quality Committee Review date: June 2022 Management of women with decreased fetal movements Hutt Maternity Policies provide guidance for the midwives and medical staff working in Hutt Maternity Services. Please discuss policies relevant to your care with your Lead Maternity Carer. Purpose Maternal concern about decreased fetal movements (DFM) is common and occurs in 4- 16% of pregnancies. The majority of cases are transient and benign however, DFM is associated with numerous adverse outcomes including small for gestation age (SGA), oligohydramnios, perinatal brain injuries, intrauterine infections, congenital abnormalities, feto-maternal haemorrhage, umbilical cord complications, stillbirths and neonatal deaths.1 Emerging evidence suggests that dissemination of information regarding fetal movements to pregnant women and timely assessment of maternal reports of DFM may reduce adverse outcomes. 2 The purpose of this policy is to ensure timely and appropriate assessment of DFM complaints. Scope This policy is intended to apply to women with otherwise normal pregnancies who present with a concern about fetal movements. For women with identified medical or obstetric conditions, DFM may be considered an additional risk factor for poor outcome. There is a lack of high-quality evidence to guide management of cases of DFM at present, although two large trials are ongoing. Definitions A diagnosis of DFM is made based on the subjective impression of reduced fetal movements by the pregnant woman herself. This decrease may be in frequency and/or strength of movements, or constitute a change in her baby’s normal pattern of movements.
    [Show full text]